Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-12-15 Sale |
2020-12-17 6:58 pm |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,000 | $63.22 | $632,156 | 169,907 (Direct) |
View |
2020-12-09 Sale |
2020-12-11 4:14 pm |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,000 | $45 | $450,000 | 179,907 (Direct) |
View |
2020-12-07 Sale |
2020-12-08 4:12 pm |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
20,000 | $40.02 | $800,400 | 189,907 (Direct) |
View |
2020-11-09 Sale |
2020-11-10 4:13 pm |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
228 | $31.21 | $7,116 | 24,907 (Direct) |
View |
2020-10-15 Sale |
2020-10-16 4:38 pm |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
3,000 | $31.39 | $94,170 | 25,135 (Direct) |
View |
2020-08-17 Sale |
2020-08-19 4:44 pm |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,000 | $35.29 | $352,900 | 213,135 (Direct) |
View |
2020-08-06 Sale |
2020-08-10 4:24 pm |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,238 | $37.41 | $383,028 | 223,135 (Direct) |
View |
2020-07-15 Sale |
2020-07-17 5:32 pm |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
3,000 | $32.22 | $96,660 | 28,373 (Direct) |
View |
2020-05-06 Sale |
2020-05-08 4:17 pm |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
151 | $25.28 | $3,817 | 31,373 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2020-12-15 Exercise |
2020-12-17 6:58 pm |
N/A 2026-09-08 |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,000 | $0 | 169,907 (Direct) |
View |
2020-12-15 Exercise |
2020-12-17 6:58 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,000 | $16.51 | 169,907 (Direct) |
View |
2020-12-09 Exercise |
2020-12-11 4:14 pm |
N/A 2026-09-08 |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,000 | $0 | 179,907 (Direct) |
View |
2020-12-09 Exercise |
2020-12-11 4:14 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,000 | $16.51 | 179,907 (Direct) |
View |
2020-12-07 Exercise |
2020-12-08 4:12 pm |
N/A 2026-09-08 |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
20,000 | $0 | 189,907 (Direct) |
View |
2020-12-07 Exercise |
2020-12-08 4:12 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
20,000 | $16.51 | 189,907 (Direct) |
View |
2020-08-17 Exercise |
2020-08-19 4:44 pm |
N/A 2026-09-08 |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,000 | $0 | 213,135 (Direct) |
View |
2020-08-17 Exercise |
2020-08-19 4:44 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,000 | $16.51 | 213,135 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:24 pm |
N/A 2026-09-08 |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,000 | $0 | 223,135 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:24 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer |
10,000 | $16.51 | 223,135 (Direct) |
View |